16 results
Histologic Features and Prevalence of Nonalcoholic Steatohepatitis (NASH). NASH is a potentially progressive type of nonalcoholic
Steatohepatitis (NASH ... NASH is a potentially ... #Pathology #Epidemiology ... #Progression #HCC ... #Prevalence #NEJM
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment #EBM #Hepatology #HCV #CKD #Glecaprevir
Patients with HCV ... Renal Impairment #EBM ... #Hepatology #HCV ... VisualAbstract #NEJM
Excoriated papules with honey-colored crusting were present on the abdomen, back (Panel A), arms, and legs.
Clinical #Derm #Pathology ... Scabies #Microscopy #Rash ... #NEJM
Strongyloides stercoralis Hyperinfection - Physical examination revealed reticulated purpuric patches with dusky centers on the abdomen,
biopsy of the rash ... Clinical #Derm #Pathology ... InfectiousDisease #Rash ... FilariformLarvae #Microscopy #NEJM
Tinea Versicolor - Physical examination revealed large, coalescing, hypopigmented patches and macules on her torso and
Clinical #Derm #Pathology ... TineaVersicolor #Rash ... Microscopy #Spaghetti #NEJM
Rate of Survival and the Risk of Death at 90 Days, According to Subgroup #EBM #PCC
According to Subgroup #EBM ... #PCC #ADRENAL # ... #SepticShock #NEJM
Summary of the 10 Most Common Histopathological Diagnoses among 9523 Patients Who Underwent Epilepsy Surgery. #Diagnosis
#Diagnosis #EBM ... #Neuro #Pathology ... #Differential #NEJM
CNS Infections - Viral Encephalitis and Bacterial Meningitis - Differential Diagnosis Framework

Viral Encephalitis:
MCC: Enteroviruses (e.g., coxsackievirus
Encephalitis: MCC ... Herpesviruses (MCC ... virus • CMV • EBV ... Maculopapular rash ... • Uveitis • Rash
Associations between Total Mucin Concentrations and Phlegm Production and Disease Severity in Chronic Obstructive Pulmonary Disease
#EBM #Pathophys ... #PCC #Bronchitis ... ChronicBronchitis #Mucin #NEJM
Tezepelumab in Adults with Uncontrolled Asthma - Annualized Rate of Asthma Exacerbations at Week 52, According
Nitric Oxide #EBM ... #PCC #Asthma #Tezepelumab ... #NEJM